Trying to separate three different claims about LL-37: that it is the right molecule, that it is the right dose, and that it does something useful.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Tolerance and underdosing look identical from the inside, which is why the answer is usually a blood test and not more forums.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Vivid dreams and mild headache for the first 8 days, then nothing. Textbook for this class, apparently.
Posting to be argued with, mainly.
This is the kind of post the forum exists for.
Narrow conclusion.
This board overrates bloodwork. A number moving is not the outcome you wanted.
Narrow conclusion.
Baseline first.
Narrow conclusion.
A plausible mechanism is not an outcome, and this class is the textbook example.
This board overrates bloodwork. A number moving is not the outcome you wanted.
How long before you can reasonably say something is or is not doing anything?
A plausible mechanism is not an outcome, and this class is the textbook example. Same for me with LL-37, unfortunately.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Nobody has ever been talked out of a stack by a stranger on the internet.
How long before you can reasonably say something is or is not doing anything? Two years in on LL-37 and it lines up.
Where does the human data stop and the extrapolation begin? That is the whole thread.